Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production.

[1]  M. Tomonaga,et al.  Multi-clonal expansion of unique human T-lymphotropic virus type-I-infected T cells with high growth potential in response to interleukin-2 in prodromal phase of adult T cell leukemia , 1999, Leukemia.

[2]  A. Cereseto,et al.  Human T-Cell Lymphotropic/Leukemia Virus Type 1 Tax Abrogates p53-Induced Cell Cycle Arrest and Apoptosis through Its CREB/ATF Functional Domain , 1998, Journal of Virology.

[3]  M. Tomonaga,et al.  Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor alpha on ATL cells. , 1998, Blood.

[4]  H. Kalthoff,et al.  Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. , 1998, Cancer research.

[5]  M. Matsuoka,et al.  Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients. , 1998, AIDS research and human retroviruses.

[6]  I. Herr,et al.  Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). , 1997, Blood.

[7]  M. Tomonaga,et al.  Soluble and membrane isoforms of Fas/CD95 in fresh adult T‐cell leukemia (ATL) cells and ATL‐cell lines , 1997, International journal of cancer.

[8]  John Calvin Reed,et al.  Repression of bax gene expression by the HTLV-1 Tax protein: implications for suppression of apoptosis in virally infected cells. , 1997, Virology.

[9]  W. Dalton,et al.  Selection for drug resistance results in resistance to Fas-mediated apoptosis. , 1997, Blood.

[10]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[11]  John Calvin Reed,et al.  FAP-1: a protein tyrosine phosphatase that associates with Fas. , 1995, Science.

[12]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[13]  M. Tomonaga,et al.  Established IL‐2‐dependent double‐negative (CD4‐ CD8‐) TCRαβ/CD3+ ATL cells: induction of CD4 expression , 1994 .

[14]  Matthew J. Brauer,et al.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. , 1994, Science.

[15]  Atsushi Hase,et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.

[16]  M. Tomonaga,et al.  IL-2-dependent ATL cell lines with phenotypes differing from the original leukemia cells. , 1991, Leukemia research.

[17]  P. Möller,et al.  Monoclonal antibody-mediated tumor regression by induction of apoptosis. , 1989, Science.

[18]  S. Yonehara,et al.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.

[19]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[20]  Y. Yamada.  Phenotypic and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma. , 1983, Blood.

[21]  M. Yoshida,et al.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Bunn,et al.  Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas , 1981, The Journal of experimental medicine.

[23]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.

[24]  J. Yodoi,et al.  Adult T-cell leukemia: clinical and hematologic features of 16 cases. , 1977, Blood.